Ulm, Germany

Heparegenix Gmbh


USPTO Granted Patents = 7


Forward Citations = 13

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Wolfgang Albrecht (7 out of 44 patents)

silverMedal Roland Selig (7 out of 13 patents)

bronzeMedal Stefan Laufer (7 out of 22 patents)

4.  Phillip Klövekorn (2 out of 2 patents)

5.  Bent Präfke (2 out of 2 patents)

6.  Philip Klövekorn (2 out of 2 patents)

7.  Bent Praefke (2 out of 2 patents)

8.  Michael Juchum (1 out of 1 patent)

9.  Bent Pfaffenrot (1 out of 1 patent)

10.  Philip KLÖVEKORN (0 patent)


7 patents:

Company Overview
Heparegenix GmbH is a biotechnology company dedicated to developing innovative therapies for liver diseases. Our focus is on advancing therapeutic approaches for conditions such as chronic hepatitis, cirrhosis, and liver cancer. With a team of experienced scientists and clinicians, we are committed to improving the lives of patients worldwide through our groundbreaking research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#19 in Ulm

#4,860 in Germany

Ulm, DE
Ulm, Germany
Forward Citations = 13

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Heparegenix Gmbh. Retrieved from https://idiyas.com/company/heparegenix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…